FDA approves botox for spasticity

News

FDA approves botox for spasticity

12 Mar, 2010

Published over 16 years ago. See the latest and most current information on News.

Botox can now be used as a treatment for people suffering from spasticity following US Food and Drug Administration (FDA) approval.

Individuals who have tremors in their elbow, wrist and fingers could benefit from the decision, with the condition prevalent in those who have multiple sclerosis, brain injuries or have had a stroke.

Temporarily blocking signals between the nerves and muscles, botox is able to paralyse spastic limbs for a short-term period.

Director of the neurology products division of the FDA's centre for drug evaluation and research Russell Katz said it could help patients to cope with the condition more easily.

"Muscles affected by spasticity have increased stiffness and tightness, which may lead to pain, difficulties with hygiene and other activities of daily living and may affect how a patient looks," he remarked.

According to the Multiple Sclerosis International Federation, more than two million people have the disease worldwide, with weak and unsteady limbs a common symptom.

Latest News

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Connected safety technology company announces CEO appointment and leadership transition
Explore more Arrow
Pollution Solutions Online
Smarter wastewater management helps futureproof distillery operations and protect local watercourses
Explore more Arrow
Petro Online
Sustainable fuel lubricity testing in focus at Gulf Coast Conference 2026
Explore more Arrow
Chromatography Today
Dr. Anupam Giri joins Chromatography Today as consultant editor to strengthen its technical expertise
Explore more Arrow